Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Damian T. Rieke - , Charité – Universitätsmedizin Berlin (Author)
  • Michael Bitzer - , University Hospital Tübingen (Author)
  • Annalen Bleckmann - , University of Münster (Author)
  • Alexander Desuki - , University Medical Center Mainz (Author)
  • Thomas Ernst - , Friedrich Schiller University Jena (Author)
  • Irene Esposito - , Heinrich Heine University Düsseldorf (Author)
  • Armin Gerger - , Medical University of Graz (Author)
  • Hanno Glimm - , National Center for Tumor Diseases Dresden, University Hospital Carl Gustav Carus Dresden, Department for Translational Medical Oncology, National Center for Tumor Diseases Dresden (NCT/UCC), a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden University of Technology, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany. alexander.wurm@nct-dresden.de. (Author)
  • Peter Horak - , German Cancer Research Center (DKFZ) (Author)
  • Daniel Hübschmann - , German Cancer Research Center (DKFZ) (Author)
  • Anna Lena Illert - , Technical University of Munich (Author)
  • Volker Kunzmann - , University of Würzburg (Author)
  • Sonja Loges - , Heidelberg University  (Author)
  • Ina Pretzell - , University of Duisburg-Essen (Author)
  • Katja Schmitz - , Tyrolpath Obrist Brunhuber GmbH, Krankenhaus St. Vinzenz Zams (Author)
  • Andreas Seeber - , Innsbruck Medical University (Author)
  • Bärbel Söhlke - , Zielgenau e.V. (Author)
  • Andreas Wicki - , University of Zurich (Author)
  • Jürgen Wolf - , University of Cologne (Author)
  • Georg Maschmeyer - , German Society for Hematology and Medical Oncology eV (Author)

Abstract

Precision oncology is a multi-step process including patient selection, tumor profiling, molecular tumor board discussion and personalized cancer management. So far, it remains largely unstandardized. The implementation of precision oncology can be beneficial for patients but implementation differs widely between tumor types and local practices. A working group was established by the Austrian, German and Swiss societies for Hematology and Medical Oncology to establish an expert consensus on evidence-based standards and implementation of precision oncology. Herein, we present a summary of this guideline. The full documents are available at www.onkopedia-guidelines.info

Details

Original languageEnglish
Article number115331
JournalEuropean journal of cancer
Volume220
Publication statusPublished - 2 May 2025
Peer-reviewedYes

External IDs

PubMed 40058270
ORCID /0009-0003-2782-8190/work/198593812

Keywords

ASJC Scopus subject areas

Keywords

  • Molecular Oncology, Personalized medicine, Precision Oncology, Targeted therapy